Inside the Science of Pediatric Lung Disease: A Special Section
Inside the Science of Pediatric Lung Disease: A Special Section https://pediatricsnationwide.org/wp-content/uploads/2026/04/lung-cover_final-copy-header-1024x624.jpg 1024 624 Abbie Miller https://pediatricsnationwide.org/wp-content/uploads/2023/05/051023BT016-Abbie-Crop.jpg
A NOTE FROM THE EDITOR
Our breath connects us with the moment, grounds us and has the power to calm our minds and bodies. But for millions of children, an easy breath is not guaranteed.
Lung disease accounts for about a third of admissions to children’s hospitals. From the common culprits, such as asthma, to rare lung diseases, such as cystic fibrosis and sickle cell lung disease, our researchers are working to understand mechanisms of disease, recovery and prevention through basic science studies and landmark clinical trials.
In a unique culture of collaboration, researchers from across the organization, including those in the Center for Perinatal Research, Center for Clinical and Translational Research and Center for Microbe and Immunity Research are working with colleagues in Critical Care Medicine, Pulmonology and Allergy and Asthma, in novel ways to connect the dots on lifelong lung health.
Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in infants born preterm. Nationwide Children’s Hospital has long been recognized as a leader in clinical care for these vulnerable patients, with a dedicated BPD Unit housed within the neonatal intensive care unit (NICU). Now, researchers are building a novel study to understand BPD in ways we haven’t even been able to attempt before.
In the articles in this special section, you’ll dive into some of the projects and programs at Nationwide Children’s that are poised to improve our understanding of lung disease to drive better outcomes for children everywhere.
I hope you enjoy them as much as I have.
– Abbie Miller, MS, MWC
From Bronchopulmonary Dysplasia to Chronic Obstructive Pulmonary Disease: A Developmental Continuum
Beyond Modulators: Ensuring All Patients With Cystic Fibrosis Benefit From the Next Wave of Therapy
These articles appeared in the 2026 Spring/Summer print issue. Download the issue here.
About the author
Abbie (Roth) Miller, MS, MWC, is a passionate communicator of science. As the manager of medical and science content at Nationwide Children’s Hospital, she shares stories about innovative research and discovery with audiences ranging from parents to preeminent researchers and leaders. She is a Medical Writer Certified®, credentialed by the American Medical Writers Association, and received her masters of science in Health Communication from Boston University.
- Abbie Millerhttps://pediatricsnationwide.org/author/abbie-miller/
- Abbie Millerhttps://pediatricsnationwide.org/author/abbie-miller/
- Abbie Millerhttps://pediatricsnationwide.org/author/abbie-miller/
- Abbie Millerhttps://pediatricsnationwide.org/author/abbie-miller/
